Critical Care News and Research

RSS

Exempla Healthcare selects ProVation MD for streamlined procedure documentation and coding

Wolters Kluwer Health, a leading global provider of information for healthcare professionals and students, announced today that Exempla Healthcare has selected its ProVation® MD software for gastroenterology and pulmonary procedure documentation and coding. ProVation MD will be deployed across three hospitals in the nationally recognized Exempla Healthcare System.

9 Nov 2010

New techniques to stop ventricular arrhythmias in high-risk patients

New techniques now being used at UCLA allow doctors to more precisely target certain areas of the heart to stop ventricular arrhythmias — serious abnormal rhythms in the heart's lower chambers — in high-risk patients.

9 Nov 2010

NxStage Medical third quarter net revenue increases 18% to $45.0 million

NxStage Medical, Inc., a leading manufacturer of innovative dialysis products, today reported record financial results for the third quarter of 2010 ended September 30, 2010.

4 Nov 2010

EUSA Pharma announces 10-year outcome data of PROSTASCINT in prostate cancer radiotherapy

EUSA Pharma, a transatlantic specialty pharmaceutical company focused on oncology, oncology supportive care and critical care, announced today the publication of 10-year outcome data showing that PROSTASCINT(R) (capromab pendetide) fusion imaging is an effective tool for targeting and guiding the dosing of prostate cancer radiotherapy.

4 Nov 2010

SPRC receives funds from SAMHSA to focus on populations at high risk for suicide

In the United States, suicide claims over 34,000 lives annually, the equivalent of 94 suicides per day; one suicide every 15 minutes. To address this national crisis the Substance Abuse and Mental Health Services Administration (SAMHSA) is awarding a total of up to $22.4 million in additional funds over the course of the next five years to the Suicide Prevention Resource Center (SPRC).

4 Nov 2010

EUSA announces publication of PROSTASCINT imaging for prostate cancer in official journal of American Society

EUSA Pharma, a transatlantic specialty pharmaceutical company focused on oncology, oncology supportive care and critical care, announced today the publication of 10-year outcome data showing that PROSTASCINT (capromab pendetide) fusion imaging is an effective tool for targeting and guiding the dosing of prostate cancer radiotherapy.

3 Nov 2010

Study reveals positive correlation between specialty nursing certification and workplace empowerment

Building on the body of evidence supporting a link between specialty nursing certification and workplace empowerment, a new study documents a positive association between nurses' perceptions of workplace empowerment and the proportion of nurses with specialty certification in hospital units.

3 Nov 2010

Asthmatx presents 2-year results from AIR2 Trial of bronchial thermoplasty in severe asthma

Boston Scientific Corporation today announced that its newly acquired subsidiary, Asthmatx, Inc., presented two-year results from the Asthma Intervention Research 2 (AIR2) Trial demonstrating the long-term safety and effectiveness of bronchial thermoplasty (BT) in adult patients with severe asthma.

2 Nov 2010

Older adults are three times as likely to die following ground-level fall

While simple falls, such as slipping while walking off a curb, may seem relatively harmless, they can actually lead to severe injury and death in elderly individuals, according to a new study published in The Journal of Trauma: Injury, Infection, and Critical Care.

2 Nov 2010

Integra LifeSciences signs multi-year contract with The Broadlane Group

Integra LifeSciences Holdings Corporation announced today that it has signed a multi-year contract with The Broadlane Group to provide dural repair, neuro trauma (neuro critical care), and hydrocephalus products and accessories to its client hospitals.

1 Nov 2010

Surrogates preference increases for value-laden decisions in ICUs: Report

The decision to stop life-support for incapacitated and critically ill patients is, for surrogate decision makers, often fraught with moral and ethical uncertainty, and long-term emotional consequences. But as difficult as these decisions are, more than half of surrogate decision makers prefer to have full authority over the choice than to share or cede that power to physicians, according to a recent study out of the University of Pittsburgh School of Medicine.

30 Oct 2010

Hikma to acquire Baxter's US generic injectables business

Hikma Pharmaceuticals PLC ("Hikma"), the fast growing multinational pharmaceutical group, announces that it has signed an agreement to acquire Baxter Healthcare Corporation's US generic injectables business ("Multi-Source Injectables" or the "Business") for a cash consideration of $112 million.

30 Oct 2010

APP receives FDA marketing approval for Metoprolol Tartrate Injection

APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to market Metoprolol Tartrate Injection, USP, and expects to launch the medication soon.

30 Oct 2010

AACN joins call for system-wide programs for medication reconciliation

The American Association of Critical-Care Nurses (AACN) added its bold voice to hospital healthcare leaders by endorsing a white paper that calls for system-wide programs for medication reconciliation — the process of verifying that current patient medications are correct, medically safe and necessary.

28 Oct 2010

Zyvox achieves higher clinical success rate than vancomycin in MRSA nosocomial pneumonia study

Results of a new international phase 4 study of patients with nosocomial pneumonia due to proven methicillin-resistant Staphylococcus aureus (MRSA) demonstrated that the antibiotic Zyvox® (linezolid) achieved a statistically significantly higher clinical success rate compared with vancomycin for the primary endpoint. The ZEPHyR (Linezolid in the treatment of subjects with nosocomial pneumonia proven to be due to methicillin-resistant Staphylococcus aureus) study was the largest ever conducted in this population.

21 Oct 2010

Z-Medica enters agreement with two Swedish medical device distributors for QuikClot products

Z-Medica Corporation, a medical device company developing innovative hemostatic agents, today announced that it has signed exclusive distribution agreements with Vingmed AB and Mediplast AB, two leading Swedish medical device distributors, for distribution of its QuikClot line of hemostatic agents in Sweden, Denmark and Norway for the first time.

From Medica Corporation 21 Oct 2010

Cipla launches generic Pirfenidone for IPF

Cipla, among the world's leading generic pharmaceutical companies, has introduced Pirfenidone in India under the brand name Pirfenex, for the treatment of IPF. A chronic progressive form of lung disease, IPF has average survival rates as low as 3-5 years which is less than many cancers. Till now there is no approved treatment for IPF.

20 Oct 2010

Elsevier / MC Strategies partners with AORN to develop latest module for Perioperative Collection

Elsevier / MC Strategies a pioneer in providing e-learning solutions to more than 1,300 healthcare organizations, has partnered with the Association of periOperative Registered Nurses (AORN) to develop the latest module for Mosby's Nursing Skills Perioperative Collection, the only perioperative-specific set of nursing skills approved by AORN to be consistent with the Standards and Recommended Practices.

20 Oct 2010

Beryl Institute awards $1,000 grants to health care organizations

As part of its commitment to supporting efforts to improve the patient experience in healthcare, The Beryl Institute has awarded $1,000 grants to ten health care organizations that are exploring effective methods for addressing patient experience issues.

20 Oct 2010

Study reveals sex hormones can influence structure and function of heart's right ventricle

In the largest human study to date on the topic, researchers have uncovered evidence of the possible influence of human sex hormones on the structure and function of the right ventricle (RV) of the heart.

20 Oct 2010

Critical Care News and Research

Exempla Healthcare selects ProVation MD for streamlined procedure documentation and coding

New techniques to stop ventricular arrhythmias in high-risk patients

NxStage Medical third quarter net revenue increases 18% to $45.0 million

EUSA Pharma announces 10-year outcome data of PROSTASCINT in prostate cancer radiotherapy

SPRC receives funds from SAMHSA to focus on populations at high risk for suicide

EUSA announces publication of PROSTASCINT imaging for prostate cancer in official journal of American Society

Study reveals positive correlation between specialty nursing certification and workplace empowerment

Asthmatx presents 2-year results from AIR2 Trial of bronchial thermoplasty in severe asthma

Older adults are three times as likely to die following ground-level fall

Integra LifeSciences signs multi-year contract with The Broadlane Group

Surrogates preference increases for value-laden decisions in ICUs: Report

Hikma to acquire Baxter's US generic injectables business

APP receives FDA marketing approval for Metoprolol Tartrate Injection

AACN joins call for system-wide programs for medication reconciliation

Zyvox achieves higher clinical success rate than vancomycin in MRSA nosocomial pneumonia study

Z-Medica enters agreement with two Swedish medical device distributors for QuikClot products

Cipla launches generic Pirfenidone for IPF

Elsevier / MC Strategies partners with AORN to develop latest module for Perioperative Collection

Beryl Institute awards $1,000 grants to health care organizations

Study reveals sex hormones can influence structure and function of heart's right ventricle

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News